©The Author(s) 2025.
World J Gastrointest Oncol. Oct 15, 2025; 17(10): 109506
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.109506
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.109506
Table 1 Patient characteristics at baseline, n (%)/mean ± SD
| Characteristic | Value or case |
| Male | 83 (66.40) |
| Age (years) | 56.74 ± 11.25 |
| BMI (kg/m2) | 23.58 ± 3.45 |
| History of hepatitis B | 63 (50.40) |
| Alcoholic liver disease | 19 (15.20) |
| Family history of liver cancer | 28 (22.40) |
| ALT (U/L) | 48.73 ± 21.16 |
| AST (U/L) | 44.82 ± 19.87 |
| ALB (g/L) | 38.42 ± 4.37 |
| TBIL (μmol/L) | 22.48 ± 6.89 |
| AFP (ng/mL) | 392.35 ± 106.33 |
| Single lesion | 91 (72.80) |
| Maximum diameter of lesion (cm) | 3.74 ± 1.85 |
| Clear boundary | 88 (70.40) |
| Hypoechoic lesions | 72 (57.60) |
- Citation: Dong Y, Chen LP, He JG, Yang QQ, Hu ZW. Clinical value of contrast-enhanced ultrasound in early diagnosis of hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(10): 109506
- URL: https://www.wjgnet.com/1948-5204/full/v17/i10/109506.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i10.109506